Trial Profile
1-year retrospective observational study of Perampanel in primary generalized epilepsies.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2016
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Generalised epilepsy
- Focus Adverse reactions; Therapeutic Use
- 25 Sep 2016 New trial record